CONFIRM trial Protocol: The utility of PSMA PET/CT in active surveillance for prostate cancer. Bagguley D, Harewood L, McKenzie D, Ptasznik G, et al. BJU Int 2023 Oct 30. doi: 10.1111/bju.16214.

Read + Share

Amedeo Smart

Independent Medical Education

Bagguley D, Harewood L, McKenzie D, Ptasznik G, et al. CONFIRM trial Protocol: The utility of PSMA PET/CT in active surveillance for prostate cancer. BJU Int 2023 Oct 30. doi: 10.1111/bju.16214.
PMID: 37904302